MCAF5352A

DRUG2 trials

Sponsors

Genentech, Inc.

Conditions

Healthy Volunteer

Phase 1

Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of Subcutaneous MCAF5352A in Healthy Volunteers

CompletedNCT01480310

Genentech, Inc.Healthy Volunteer

Start: 2011-12-31End: 2012-06-30Updated: 2016-11-02

A Study of MCAF5352A in Healthy Volunteers

CompletedNCT01540760

Genentech, Inc.Healthy Volunteer

Start: 2012-03-31End: 2012-09-30Updated: 2016-11-02